Foglia Partners, with a team coordinated by Giuliano Foglia and Matteo Carfagnini composed of Francesco Capogrossi and Maddalena Cecci, advisedTrilantic Europe, handling all the tax aspects of the integration of its portfolio company Doppel Farmaceutici with Mipharm S.p.A., a subsidiary of Alto Partners SGR S.p.A., which resulted in the birth of DMX PHARMA.
Doppel Farmaceutici, founded in 1994, is a contract development and manufacturing organization (CDMO), offering fully integrated drug development and manufacturing solutions to the pharmaceutical market.
Together, the two companies will have more than 900 employees and serve a global portfolio of 100 “blue-chip” customers, with four plants located in Milan, Piacenza and Ferrara and an aggregate turnover of about 180 million.